Document is current
Any future updates will be listed below
-
Authors
Tanevski, Jovan
Flores, Ricardo Omar Ramirez
Gabor, Attila
Schapiro, Denis
Saez-Rodriguez, Julio http://orcid.org/0000-0002-8552-8976
-
Funding
Funding for this research was provided by:
Ministrstvo za Izobraževanje, Znanost in Šport (C3330-17-529021)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2ZHP3_181475)
Damon Runyon Cancer Research Foundation (DRQ-03-20)
Bundesministerium für Bildung und Forschung (01ZZ2004)
Medizinische Fakultät Heidelberg der Universität Heidelberg
- License Information
-
More Information
Article History
Received: 29 October 2021
Accepted: 1 April 2022
First Online: 14 April 2022
Declarations
:
: Not applicable.
: J.S.R. receives funding from GSK and Sanofi and consultant fees from Travere Therapeutics and Astex Pharmaceutical. D.S. is a consultant for Roche Glycart AG.
